Infinity Stock Today

INFI -  USA Stock  

USD 2.74  0.08  3.01%

Infinity Pharmaceuti is trading at 2.74 as of the 21st of October 2021. This is a 3.01 percent up since the beginning of the trading day. The stock's open price was 2.66. Infinity Pharmaceuti has a very small chance of experiencing financial distress in the next few years but had a somewhat insignificant performance during the last 90 days. Equity ratings for Infinity Pharmaceuti are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 21st of September 2021 and ending today, the 21st of October 2021. Click here to learn more.
 Market Performance
4 of 100
  Odds Of Distress
Less than 2
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. The company has 88.65 M outstanding shares of which 5.1 M shares are currently shorted by private and institutional investors with about 2.19 trading days to cover. More on Infinity Pharmaceuti

Infinity Pharmaceuti Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Infinity Pharmaceuti's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Infinity Pharmaceuti or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Infinity Pharmaceuti is way too risky over 90 days horizon
Infinity Pharmaceuti appears to be risky and price may revert if volatility continues
Infinity Pharmaceuti is unlikely to experience financial distress in the next 2 years
Infinity Pharmaceuti was previously known as Infinity Pharmaceuticals and was traded on NASDAQ Exchange under the symbol DPII.
The company reported the previous year's revenue of 1.91 M. Net Loss for the year was (43.03 M) with loss before overhead, payroll, taxes, and interest of (26.08 M).
Infinity Pharmaceuti currently holds about 97.26 M in cash with (39.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.1.
Infinity Pharmaceuti has a frail financial position based on the latest SEC disclosures
Roughly 57.0% of the company shares are owned by institutional investors
Infinity Pharmaceuti Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Infinity Pharmaceuti SEC Filings
Infinity Pharmaceuti SEC Filings Security & Exchange Commission EDGAR Reports
Legal NameInfinity Pharmaceuti
Older SymbolDPII
ChairmanAdelene Perkins  (View All)
Average Analyst Recommendation
Analysts covering Infinity Pharmaceuti report their recommendations after researching Infinity Pharmaceuti's financial statements, talking to executives and customers, or listening in on Infinity Pharmaceuti's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Infinity Pharmaceuti. The Infinity consensus assessment is calculated by taking the average forecast from all of the analysts covering Infinity Pharmaceuti.
Strong Buy6 Opinions
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Infinity Pharmaceuti based on its profitability, leverage, liquidity, source of funds, and operating efficiency. it is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Infinity Pharmaceuti financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 3 - FrailDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares58 M59.9 M
Sufficiently Down
Increasing
Slightly volatile
Weighted Average Shares Diluted58 M59.9 M
Sufficiently Down
Increasing
Slightly volatile
Net Cash Flow from Operations(38.6 M)(35.7 M)
Significantly Down
Increasing
Very volatile
Total Assets40.4 M39.3 M
Fairly Up
Decreasing
Slightly volatile
Total Liabilities61.7 M62.3 M
Slightly Down
Decreasing
Stable
Current Assets37 M36 M
Fairly Up
Decreasing
Slightly volatile
Current Liabilities16.8 M11 M
Way Up
Decreasing
Slightly volatile
Total Debt1.5 M1.4 M
Fairly Up
Decreasing
Slightly volatile
Gross Margin0.890.9
Fairly Down
Decreasing
Slightly volatile
Asset Turnover0.03690.036
Fairly Up
Decreasing
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Infinity Pharmaceuti's available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Financial Strength
Infinity Pharmaceuti's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Infinity Pharmaceuti's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Infinity Pharmaceuti's financial leverage. It provides some insight into what part of Infinity Pharmaceuti's total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Infinity Pharmaceuti's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Infinity Pharmaceuti deploys its capital and how much of that capital is borrowed.
Liquidity
Infinity Pharmaceuti cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 1.69 M in liabilities with Debt to Equity (D/E) ratio of 0.04, which may suggest the company is not taking enough advantage from borrowing. Infinity Pharmaceuti has a current ratio of 9.25, suggesting that it is liquid enough and is able to pay its financial obligations when due.

Operating Cash Flow

(38.56 Million)Share
Infinity Pharmaceuti (INFI) is traded on NASDAQ Exchange in USA. It is located in 1100 Massachusetts Avenue, Floor 4, Cambridge, MA 02138, United States and employs 23 people. Infinity Pharmaceuti was previously known as Infinity Pharmaceuticals and was traded on NASDAQ Exchange under the symbol DPII. Infinity Pharmaceuti is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Small-Cap' category with current market capitalization of 234.03 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Infinity Pharmaceuti's market, we take the total number of its shares issued and multiply it by Infinity Pharmaceuti's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Infinity Pharmaceuti conducts business under Healthcare sector and is part of Biotechnology industry. The entity has 88.65 M outstanding shares of which 5.1 M shares are currently shorted by private and institutional investors with about 2.19 trading days to cover. Infinity Pharmaceuti currently holds about 97.26 M in cash with (39.43 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.1.
Check Infinity Pharmaceuti Probability Of Bankruptcy
Ownership
Infinity Pharmaceuti has a total of eighty-eight million six hundred fifty thousand outstanding shares. Over half of Infinity Pharmaceuti outstanding shares are owned by outside corporations. These outside corporations are typically referred to corporate investors that purchase positions in a given instrument to benefit from reduced trade commissions. Consequently, these institutions are subject to different rules and regulation than regular investors in Infinity Pharmaceuti. Please watch out for any change in the institutional holdings of Infinity Pharmaceuti as this could mean something significant has changed or about to change at the company. Please note that no matter how much assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Infinity Ownership Details

Infinity Stock Price Odds Analysis

What are Infinity Pharmaceuti's target price odds to finish over the current price? In reference to a normal probability distribution, the odds of Infinity Pharmaceuti jumping above the current price in 90 days from now is about 77.18%. The Infinity Pharmaceuti probability density function shows the probability of Infinity Pharmaceuti stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Infinity Pharmaceuti has a beta of 0.3763. This usually indicates as returns on the market go up, Infinity Pharmaceuti average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding Infinity Pharmaceuti will be expected to be much smaller as well. Additionally, the company has an alpha of 0.4809, implying that it can generate a 0.48 percent excess return over DOW after adjusting for the inherited market risk (beta).
 Odds Down 2.74HorizonTargetOdds Up 2.74 
22.74%90 days
 2.74 
77.18%
Based on a normal probability distribution, the odds of Infinity Pharmaceuti to move above the current price in 90 days from now is about 77.18 (This Infinity Pharmaceuti probability density function shows the probability of Infinity Stock to fall within a particular range of prices over 90 days) .

Infinity Pharmaceuti Historical Income Statement

Infinity Pharmaceuti Income Statement is one of the three primary financial statements used for reporting Infinity's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Infinity Pharmaceuti revenue and expense. Infinity Pharmaceuti Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Infinity Pharmaceuti Revenues is most likely to decrease significantly in the upcoming years. The last year's value of Revenues was reported at 1.72 Million. The current Research and Development Expense is estimated to increase to about 27.5 M, while Consolidated Income is projected to decrease to (43.7 M). View More Fundamentals

Infinity Stock Against Markets

Picking the right benchmark for Infinity Pharmaceuti stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Infinity Pharmaceuti stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Infinity Pharmaceuti is critical whether you are bullish or bearish towards Infinity Pharmaceuti at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Infinity Pharmaceuti without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Probability Of Bankruptcy Now

   

Probability Of Bankruptcy

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Module

Infinity Pharmaceuti Corporate Directors

Infinity Pharmaceuti corporate directors refer to members of an Infinity Pharmaceuti board of directors. The board of directors generally takes responsibility for the Infinity Pharmaceuti's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Infinity Pharmaceuti's board members must vote for the resolution. The Infinity Pharmaceuti board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Jeffrey Berkowitz - Independent DirectorProfile
Norman Selby - Lead Outside Independent DirectorProfile
Jose Baselga - Independent DirectorProfile
Michael Venuti - Independent DirectorProfile
Please see Risk vs Return Analysis. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Transaction History
View history of all your transactions and understand their impact on performance
Go
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Go
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Go
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Go
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Go
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.